bioRxiv Science⌕ Search

Biology subjects

Heffernan, L. M.

Publications and source records attributed to Heffernan, L. M..

2 recordsLinked to original sources

Exposure to immune stimuli reprograms alveolar macrophages to acquire neutrophil-derived antimicrobial molecules to prevent staphylococcal pneumonia

The protective adaptation of innate immune defenses against respiratory pathogens has been linked to previous exposure to immune stimuli; however, the underlying mechanisms of these adaptations are not yet fully understood. Here, we show that pre-exposure to a low dose of non-specific immune stimuli or infection protects against subsequent lethal methicillin-resistant Staphylococcus aureus (MRSA) challenge. This enhanced protection concurs with increased alveolar macrophages (AMs) resulting from a self-renewal process in the lungs. Importantly, these AMs are programmed to acquire neutrophil-released antimicrobial enzymes from the extracellular space to kill MRSA, prevent tissue damage, and rapidly restore lung homeostasis. The gain of AM functions is dependent on differential gene expression, including expression of the efferocytosis receptor MerTK and the anti-apoptotic regulator Bcl-xL. Thus, our data highlight that the acquisition of neutrophil enzymes by AMs is an integral component of innate immune adaptation.

immunology↗

Activation of the endoplasmic reticulum stress regulator IRE1α compromises pulmonary host defenses

The endoplasmic reticulum (ER) stress sensor inositol-requiring enzyme 1- (IRE1) is associated with lung infections where innate immune cells are drivers for progression and resolution of inflammation. Yet, the role of IRE1 in pulmonary innate immune host defense during acute respiratory infection remains unexplored. Here, we found that activation of IRE1 in infected lungs compromises immunity against methicillin-resistant Staphylococcus aureus (MRSA)-induced primary and secondary pneumonia. Moreover, activation of IRE1 in MRSA-infected lungs and alveolar macrophages (AMs) leads to exacerbated production of inflammatory mediators followed by cell death. Ablation of myeloid IRE1 or global IRE1 inhibition confers protection against MRSA-induced pneumonia with improves survival, bacterial clearance, cytokine reduction, and lung injury. In addition, loss of myeloid IRE1 protects mice against MRSA-induced secondary to influenza pneumonia by promoting AM survival. Thus, activation of IRE1 is detrimental to pneumonia and therefore, it shows potential as a target to control excessive unresolved lung inflammation.

immunology↗